BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20405182)

  • 1. The role of IgA and IgA Fc receptors as anti-inflammatory agents.
    Monteiro RC
    J Clin Immunol; 2010 May; 30 Suppl 1():S61-4. PubMed ID: 20405182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives.
    Ben Mkaddem S; Rossato E; Heming N; Monteiro RC
    Autoimmun Rev; 2013 Apr; 12(6):666-9. PubMed ID: 23201915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of IgA and IgA fc receptors in inflammation.
    Monteiro RC
    J Clin Immunol; 2010 Jan; 30(1):1-9. PubMed ID: 19834792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of Arthritis by Human Monomeric IgA Through the Receptor-Mediated SH2 Domain-Containing Phosphatase 1 Inhibitory Pathway.
    Rossato E; Ben Mkaddem S; Kanamaru Y; Hurtado-Nedelec M; Hayem G; Descatoire V; Vonarburg C; Miescher S; Zuercher AW; Monteiro RC
    Arthritis Rheumatol; 2015 Jul; 67(7):1766-77. PubMed ID: 25833812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA Fc receptor I signals apoptosis through the FcRgamma ITAM and affects tumor growth.
    Kanamaru Y; Tamouza H; Pfirsch S; El-Mehdi D; Guérin-Marchand C; Pretolani M; Blank U; Monteiro RC
    Blood; 2007 Jan; 109(1):203-11. PubMed ID: 16990604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulation of inflammatory responses by immunoglobulin A receptor (FcαRI) inhibits the development of Toll-like receptor-9 signalling-accelerated glomerulonephritis.
    Watanabe T; Kanamaru Y; Liu C; Suzuki Y; Tada N; Okumura K; Horikoshi S; Tomino Y
    Clin Exp Immunol; 2011 Nov; 166(2):235-50. PubMed ID: 21985370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM.
    Pasquier B; Launay P; Kanamaru Y; Moura IC; Pfirsch S; Ruffié C; Hénin D; Benhamou M; Pretolani M; Blank U; Monteiro RC
    Immunity; 2005 Jan; 22(1):31-42. PubMed ID: 15664157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgA and FcαRI: Pathological Roles and Therapeutic Opportunities.
    Breedveld A; van Egmond M
    Front Immunol; 2019; 10():553. PubMed ID: 30984170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.
    Valerius T; Stockmeyer B; van Spriel AB; Graziano RF; van den Herik-Oudijk IE; Repp R; Deo YM; Lund J; Kalden JR; Gramatzki M; van de Winkel JG
    Blood; 1997 Dec; 90(11):4485-92. PubMed ID: 9373259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity.
    Bakema JE; van Egmond M
    Mucosal Immunol; 2011 Nov; 4(6):612-24. PubMed ID: 21937986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Fc receptor for IgA (FcalphaRI, CD89).
    Otten MA; van Egmond M
    Immunol Lett; 2004 Mar; 92(1-2):23-31. PubMed ID: 15081523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG.
    Brandsma AM; Bondza S; Evers M; Koutstaal R; Nederend M; Jansen JHM; Rösner T; Valerius T; Leusen JHW; Ten Broeke T
    Front Immunol; 2019; 10():704. PubMed ID: 31031746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease.
    Aleyd E; Heineke MH; van Egmond M
    Immunol Rev; 2015 Nov; 268(1):123-38. PubMed ID: 26497517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgA Fc receptor I is a molecular switch that determines IgA activating or inhibitory functions.
    Kanamaru Y; Blank U; Monteiro RC
    Contrib Nephrol; 2007; 157():148-52. PubMed ID: 17495454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inflammatory function of human IgA.
    Hansen IS; Baeten DLP; den Dunnen J
    Cell Mol Life Sci; 2019 Mar; 76(6):1041-1055. PubMed ID: 30498997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory ITAM signaling by Fc alpha RI-FcR gamma chain controls multiple activating responses and prevents renal inflammation.
    Kanamaru Y; Pfirsch S; Aloulou M; Vrtovsnik F; Essig M; Loirat C; Deschênes G; Guérin-Marchand C; Blank U; Monteiro RC
    J Immunol; 2008 Feb; 180(4):2669-78. PubMed ID: 18250479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IgA Immune Complexes Promote Proinflammatory Cytokine Production by Human Macrophages, Monocytes, and Kupffer Cells through FcαRI-TLR Cross-Talk.
    Hansen IS; Hoepel W; Zaat SAJ; Baeten DLP; den Dunnen J
    J Immunol; 2017 Dec; 199(12):4124-4131. PubMed ID: 29118246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgA and the IgA Fc receptor.
    van Egmond M; Damen CA; van Spriel AB; Vidarsson G; van Garderen E; van de Winkel JG
    Trends Immunol; 2001 Apr; 22(4):205-11. PubMed ID: 11274926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory ITAMs as novel regulators of immunity.
    Blank U; Launay P; Benhamou M; Monteiro RC
    Immunol Rev; 2009 Nov; 232(1):59-71. PubMed ID: 19909356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
    Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P
    MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.